AppPriceData관측된 데이터
AppPriceData
Agency for Clinical Innovation
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise.
최근 관측된 다운로드 가격은 무료입니다. 현재 결제 가격은 공식 App Store 링크에서 확인하세요.
Apple 공개 App Store 페이지에서 현재 확인되는 항목입니다. App Store Connect의 전체 상품 목록과 다를 수 있습니다.
출처: Apple 공개 App Store 페이지 · 공개 항목만 포함
Thinksulin was developed by ACI in consultation with the NSW Diabetes Taskforce and its In-hospital Management of Diabetes Mellitus Working Group and informed by: an evidence check of best practice care components of inpatient insulin management brokered by the Sax Institute for the Agency for Clinical Innovation (2024); clinician and consumer consultations; and clinical expertise.
Thinksulin aims to enhance the capacity and/or capability of junior medical officers and nursing staff responsible for prescribing and administering of insulin to patients in hospital with diabetes, although it can be used by any clinician responsible for the care of people in hospital with diabetes.
Thinksulin is a point of care app that provides information and decision support on blood glucose level targets, hypoglycaemia management, blood glucose monitoring, basal-bolus calculations, and charting and reviewing doses.
최근 관측된 App Store 데이터를 바탕으로 한 빠른 답변입니다.
최근 관측된 다운로드 가격은 Free입니다. 현재 결제 가격은 공식 App Store 링크에서 확인하세요.
Apple 공개 페이지에는 현재 이 스토어에서 0개의 구매 항목이 표시됩니다. 공개 목록은 완전하지 않을 수 있습니다.
